by Blood Advances
Although research suggests more non-White patients are undergoing and surviving hematopoietic cell transplantation (HCT), outcome disparities persist.
by Blood Advances
Scientists say better prevention strategies are needed to avoid delayed-onset cytomegalovirus (CMV) infection, which surfaces in some allogeneic hematopoietic cell transplantation (allo-HCT)...
by Nature.com
Socioeconomic disparities may narrow access to allogeneic hematopoietic cell transplantation (allo-HCT) among patients with acute myeloid leukemia (AML), but new research suggests these factors...
by Bone Marrow Transplantation
The combination of fludarabine and treosulfan 30 g/m2 (FluTreo) is gaining acceptance as reduced-toxicity conditioning (RTC) for older adults with acute myeloid leukemia or myelodysplastic...
by Blood
Highly immunosuppressive regulatory T cells (Treg) contribute to inadequate responses and eventual disease progression in myeloma patients after autologous stem cell transplantation (ASCT),...
by Dr. Andrés Gómez De León, MD
In the past 2024 Tandem meetings Erica Koranteng MD, investigator from Ghana interested in medical ethics...